Dr Jason Mellad

Jason is a scientist and entrepreneur, passionate about translating innovative technologies into better patient outcomes.

As CEO and Co-Founder of Start Codon, a UK-based accelerator, he aims to discover the most disruptive life science, BioTech and healthcare founders and help them translate their innovations into successful ventures. This is achieved through a combination of seed funding and a bespoke venture-building programme, which taps into the exceptional resources of the Cambridge cluster as well as the global network and knowledge of Jason and the Start Codon team.

Previously, he was CEO of Cambridge Epigenetix (now Biomodal) and Business Development Manager for Horizon Discovery’s diagnostics division. He also served as an associate for Cambridge Enterprise, the technology transfer office of the University of Cambridge.

Originally from Louisiana, Jason was awarded a Marshall Scholarship to complete his PhD in Medicine at the University of Cambridge (Clare College) after graduating Summa Cum Laude from Tulane University with a BSc in Molecular Biology and Chemistry. He is also a visiting Fellow at Jesus College, Cambridge, and lives in Cambridge with his husband and sons.